Fjarde AP Fonden Fourth Swedish National Pension Fund Has $10.57 Million Holdings in Becton, Dickinson and Company $BDX

Key Points

• Fjarde AP Fonden Fourth Swedish National Pension Fund has reduced its stake in Becton, Dickinson and Company by 15.7%, selling 8,600 shares and now holding 46,146 shares worth approximately $10.57 million.
• Becton, Dickinson reported $3.68 earnings per share for the last quarter, surpassing the expected $3.40, with a revenue of $5.51 billion, a 10.4% increase from the previous year.
• The company announced a quarterly dividend of $1.04 per share, reflecting an annualized dividend yield of 2.1%, to be paid on September 30th.

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its stake in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 15.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,146 shares of the medical instruments supplier's stock after selling 8,600 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Becton, Dickinson and Company were worth $10,570,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Smallwood Wealth Investment Management LLC bought a new stake in shares of Becton, Dickinson and Company during the first quarter worth $27,000. Alpine Bank Wealth Management bought a new stake in shares of Becton, Dickinson and Company during the first quarter worth $29,000. REAP Financial Group LLC increased its position in shares of Becton, Dickinson and Company by 75.3% during the fourth quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier's stock worth $29,000 after acquiring an additional 55 shares in the last quarter. Cornerstone Planning Group LLC increased its position in shares of Becton, Dickinson and Company by 341.4% during the first quarter. Cornerstone Planning Group LLC now owns 128 shares of the medical instruments supplier's stock worth $29,000 after acquiring an additional 99 shares in the last quarter. Finally, Nexus Investment Management ULC bought a new stake in shares of Becton, Dickinson and Company during the first quarter worth $34,000. Institutional investors own 86.97% of the company's stock.

Becton, Dickinson and Company Stock Performance

Shares of BDX traded up $1.2180 during midday trading on Wednesday, reaching $199.2480. The stock had a trading volume of 2,493,478 shares, compared to its average volume of 2,751,564. The firm has a 50 day simple moving average of $179.66 and a 200-day simple moving average of $196.25. Becton, Dickinson and Company has a one year low of $163.33 and a one year high of $251.99. The firm has a market cap of $57.11 billion, a PE ratio of 35.84, a P/E/G ratio of 1.48 and a beta of 0.20. The company has a current ratio of 1.10, a quick ratio of 0.62 and a debt-to-equity ratio of 0.69.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $3.68 EPS for the quarter, beating analysts' consensus estimates of $3.40 by $0.28. Becton, Dickinson and Company had a net margin of 7.51% and a return on equity of 16.23%. The company had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.50 billion. During the same quarter last year, the firm posted $3.50 EPS. The company's quarterly revenue was up 10.4% on a year-over-year basis. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. As a group, sell-side analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 8th will be given a $1.04 dividend. This represents a $4.16 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Monday, September 8th. Becton, Dickinson and Company's dividend payout ratio (DPR) is 74.82%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on BDX shares. Citigroup downgraded shares of Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating and lowered their price objective for the stock from $217.00 to $185.00 in a research report on Thursday, May 22nd. The Goldman Sachs Group downgraded shares of Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $192.00 target price for the company. in a research report on Friday, May 2nd. Barclays decreased their target price on shares of Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. Stifel Nicolaus decreased their target price on shares of Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Finally, Raymond James Financial downgraded shares of Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a research report on Friday, May 2nd. Four analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, Becton, Dickinson and Company has a consensus rating of "Hold" and a consensus target price of $211.44.

Insider Activity

In other news, Director Claire Fraser sold 863 shares of Becton, Dickinson and Company stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $192.30, for a total value of $165,954.90. Following the completion of the transaction, the director owned 23,143 shares of the company's stock, valued at $4,450,398.90. This trade represents a 3.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael David Garrison sold 1,185 shares of Becton, Dickinson and Company stock in a transaction dated Friday, July 18th. The shares were sold at an average price of $180.29, for a total transaction of $213,643.65. Following the completion of the transaction, the executive vice president directly owned 4,887 shares of the company's stock, valued at approximately $881,077.23. This trade represents a 19.52% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 3,214 shares of company stock valued at $579,206 in the last quarter. Company insiders own 0.36% of the company's stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.